This video gives insight about Prostate Cancer. Here we looked at what Prostate and Prostate Cancer is, causes of Prostate Cancer, its risk factors, diagnosis, signs and symptoms, its prevention and treatment options.Fair Use Disclaimer : Copyright disclaimer under section 107 of the copyright Act 1976, allowance is made for ‘fair use’ for purposes such as criticism, comment, news reporting, and research. Fair use is a use permitted by copyright statute that might otherwise be infringing. Non profit, educational or personal use tips the balance in favor of fair use.This video is for educational purpose only and may contain certain copyrighted materials eg. pictures for illustration. yournextdoornurse does not own any of these materials. All rights and credits go directly to its rightful owners. No copyright infringement intended.
Early detection could save lives. That is the conversation which Prostate Cancer Gibraltar wants to generate at tomorrow’s Walnut Fun Walk starting at 11am from Casemates to coincide with International Men’s Day.The Charity encourages everyone to wear light blue in support of the walk, but also to wear face coverings and maintain social distance.Jonathan Sacramento spoke to the Group’s spokesperson, Derek Ghio
Prostate cancer grows very slowly and, when confined to the prostate, does not cause serious harm. Therefore, it is vital to get screened to catch the disease before it starts spreading to the other organs. Early diagnosis increases the chances of successful treatment. This #InternationalMensDay, pledge to get screened for prostate cancer today. To consult our specialists, visit www.maxhealthcare.in or call 8860444888.#ProstateCancer #MensHealthAwarenessMonth #MenDontWait
For this Movember, Australian menswear brand Politix teamed up with visual artist Pamela Kleeman-Passi to create a unique suit using men’s mustache hair.
Prostate cancer takes a harsher toll on Black men than other American men, including other men of color. Listen for more or visit AAWellnessProject.org
This session is led by Professor Andrew Hughes, Professor of Experimental Cancer Medicine team at The University of Manchester, and previously clinical head of the Manchester Experimental Cancer Medicine Centre, one of the largest Phase 1 units in the UK.He is joined by Dr Nigel Brookes, Director Translational Science and Steven Salomon, Clinical Trials Manager, at biotechnology company, CellCentric, which has a new drug in development called “CCS1477” which is for the treatment of patients with late stage prostate cancer.
Lung cancer is the leading cause of U.S. cancer deaths. More people die from lung cancer than breast, colorectal and prostate cancers combined.
WGN PEOPLE TO PEOPLE, Racial disparities in prostate health, https://www.youtube.com/watch?v=-5g6CxK-2Ig Oakland News Now – WGN PEOPLE TO PEOPLE, Racial disparities in prostate health – video made by the YouTube channel with the logo in the video’s upper left hand corner. OaklandNewsNow.com is the original blog post for this type of video-blog content. November 13, 2021 – Dr. Jeffrey Sterling talks about the challenges Black Read More
Researchers have created and demonstrated the ability of fish-shaped microrobots, that are pH-responsive, to deliver chemotherapy drugs to cancer cells.
Thanks to funds raised by you – the Movember community – researchers have discovered the world’s first precision medicine for prostate cancer. This is how it works. To discover more about the hair-raising impact of your fundraising and donations, head to https://movember.com/impact.
Prostate Cancer is the most common cancer diagnosed in American men. PSA screening can be done with a simple blood test and should be performed yearly in men with normal risk starting at age 50 to 75. Treatment options for prostate cancer may include robotic surgery, open surgery and/or radiation. For more information talk to your primary care physician and see if a PSA screening is right for you.To learn more visit https://www.mclaren.org/main/locations/mclaren-northern-michigan-urology-582
Valley’s Hematologic Oncology Program treats all forms of blood cancer (hematologic malignancies) or blood disorders. Each patient’s case is looked at from different perspectives and, through our partnership with the Mount Sinai Health System, we offer patients the consolidated opinion of a team of doctors — at two institutions — instead of only one physician. To learn more, please visit ValleyHealth.com/Cancer.